📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Transition Support Award CSF Chris Gale

Lead Research Organisation: Imperial College London
Department Name: School of Public Health

Abstract

1 in 11 UK babies are born prematurely; many of these need neonatal care that involves medical decisions about every part of a baby's care. Many babies who require neonatal care have medical and neurological problems that affect them throughout their lives; these may be influenced by decisions made during their neonatal stay.
The ideal way to work out which clinical decision is the best is through a randomised trial. Here each baby has an equal chance of being given each treatment option and this is chosen by chance, like tossing a coin. By including lots of babies we can work out which treatment option works best. Unfortunately, randomised trials are often very expensive and burdensome. As a result, only a small number of neonatal treatment options have been tested in randomised trials and so most decisions are only educated guesses.

I want to make randomised clinical trials cheaper and easier so all day-to-day neonatal decisions can be based on the best research - randomised clinical trials. I plan to do this is by getting rid of one very expensive part, data collection, by getting all the information straight from a baby's electronic health record (EHR), a computerised version of the medical notes. Information from these EHR systems is already used for lots of purposes, I want to use it for randomised trials to make them much cheaper and easier so more can be carried out, more simply and easily.

We have already completed the following work to show that large simple neonatal trials built into EHR systems are feasible:
1. We have worked with doctors, nurses, parents, patients and researchers to determine what the most important "outcomes" for large simple neonatal trials are. An "outcome" is a result of a trial, like whether a baby needs oxygen at home
2. We have shown it is possible to carry out a moderately large, novel and pioneering trial embedded within the neonatal EHR, and have measured how accurate, simple and inexpensive this is
3. We have involved parents, doctors and nurse to make taking consent for large simple neonatal trials easier and more straightforward, and have shown that this is acceptable
4. We have worked with parents to develop a system to give parents information from the EHR about their baby rapidly and easily through a mobile app (the BUDS app)

This completed work has shown that large simple neonatal trials are feasible, but also identified some problems - particularly around how accurate and complete some information is. This work has also shown that another way to make neonatal randomised trials easier and simpler is by using 'cluster trials' where instead of the treatment each baby receives being decided by chance, the treatment a whole neonatal unit uses is decided by chance.

We want to build on this work to see if we can make neonatal EHR data better by involving parents, and to see whether large simple 'cluster trials' are possible using the neonatal EHR system. We plan to do this by:
1. Testing to see whether giving parents information from the EHR about their baby rapidly and easily through a mobile app leads to more complete and accurate data in the neonatal EHR system
2. Looking at how accurate and complete neonatal EHR data need to be for different large simple neonatal EHR trials and cluster trials to work
3. Showing that we can measure the 'outcomes' that parents, patients, doctors, nurses and researchers identified as important from neonatal EHR data

Finally we want to make sure that knowledge from large simple neonatal trials can be quickly and effectively communicated across the NHS to improve the way babies are looked after, so we will learn from the successes and mistakes of other health systems in the USA that already do this using EHR systems. We will work with neonatal doctors, nurses and researchers and with EHR companies to find the best way of doing this in the NHS.

Technical Summary

Aims of Transitional Support Award
1. Implement the BUDS app to allow parents near real-time access to their baby's data and quantify impact on routinely recorded EHR data quality
I. Continue app development
- Methods: Co-design, linkage with EHR data, implementation in London neonatal units
II. Evaluate impact on EHR data quality
- Methods: Pre/post evaluation of parent satisfaction and EHR data completeness/accuracy
III. Evaluate feasibility acceptability of BUDS app
- Methods: Structured questionnaires and qualitative interviews

2. Extract and analyse data to underpin a range of neonatal EHR-embedded trials
I. Calculate underpinning data e.g. intra-cluster coefficients/missing data proportions for core trial data items
- Methods: Analyses of EHR data in the National Neonatal Research Database (NNRD)
II. Model impact of degrees of missing/inaccurate data on individually/cluster randomised neonatal trials
- Methods: Simulate multiple individually/cluster randomised neonatal trials using NNRD data; trial effect sizes/outcomes based on published trials
- Outcomes: rates of missing/inaccurate data required to alter modelled trial findings

3. Validate the extraction of core neonatal outcomes in the NNRD
I. Identify core neonatal outcomes (prioritised earlier in the fellowship) in the NNRD; formalise extraction; validate against published and existing trial data
- Methods: Analyses NNRD data; systematic review of reported rates in similar high resource settings and large neonatal trials

4. Realise learning from research placement in Boston Veteran's Affairs and Children's Hospitals
I. Disseminate qualitative data from research placement
II. Consensus meetings to identify acceptable integration of "Learning Healthcare System" approach into NHS neonatal care

Publications

10 25 50

publication icon
Baskaran D (2023) Kernicterus in neonates from ethnic minorities in the UK. in Archives of disease in childhood. Fetal and neonatal edition

 
Title neoGASTRIC trial parent video 
Description Parent information video describing neoGASTRIC trial 
Type Of Art Film/Video/Animation 
Year Produced 2023 
Impact Novel and innovative digital media to explain opt-out consent 
URL https://www.npeu.ox.ac.uk/neogastric/parents/neogastric-trial-video
 
Description Expert Group Member: Enabling Safe, Quality Midwifery Services and Care in Northern Ireland.
Geographic Reach Local/Municipal/Regional 
Policy Influence Type Contribution to a national consultation/review
URL https://www.health-ni.gov.uk/news/department-commissions-new-report-midwifery-services-northern-irel...
 
Description Expert witness - House of Lords Committee on Preterm Birth
Geographic Reach National 
Policy Influence Type Contribution to a national consultation/review
URL https://committees.parliament.uk/committee/701/preterm-birth-committee
 
Description Accelerating the development of a perinatal platform trial to efficiently evaluate the effectiveness of multiple interventions in maternity and neonatal care
Amount £199,592 (GBP)
Funding ID NIHR156043 
Organisation National Institute for Health and Care Research 
Sector Public
Country United Kingdom
Start 03/2023 
End 02/2024
 
Description Better Outcomes in Babies with Bacterial meningitis
Amount £5,900,000 (GBP)
Funding ID NIHR166133 
Organisation National Institute for Health and Care Research 
Sector Public
Country United Kingdom
Start 08/2025 
End 09/2033
 
Description Health Technology Assessment
Amount £2,400,000 (GBP)
Funding ID NIHR134216 
Organisation National Institute for Health and Care Research 
Sector Public
Country United Kingdom
Start 08/2022 
End 09/2027
 
Description Measuring family spillover effects with EuroQol instruments over time
Amount € 134,800 (EUR)
Organisation EuroQol Group 
Sector Charity/Non Profit
Country Netherlands
Start 03/2025 
End 03/2027
 
Description Meeting global need to improve newborn care through real-world-health-data-facilitated, digital-technology-supported randomised clinical trials
Amount £656,698 (GBP)
Funding ID MR/X009831/1 
Organisation Medical Research Council (MRC) 
Sector Public
Country United Kingdom
Start 03/2023 
End 03/2025
 
Description NHMRC-NIHR Collaborative Research Grant
Amount $739,020 (AUD)
Funding ID 2014792 
Organisation National Health and Medical Research Council 
Sector Public
Country Australia
Start 08/2022 
End 09/2027
 
Description Omeprazole for Treatment of Term and preterm infants with gastro-oEsophageal Reflux (OTTER)
Amount £2,500,000 (GBP)
Organisation National Institute for Health and Care Research 
Sector Public
Country United Kingdom
Start 03/2025 
End 03/2028
 
Description Policy Research Unit in Maternal and Neonatal Health and Care
Amount £5,500,000 (GBP)
Funding ID NIHR206113 
Organisation National Institute for Health and Care Research 
Sector Public
Country United Kingdom
Start 01/2024 
End 12/2029
 
Description The Monoclonal Antibody Medications in inflammatory Arthritis: stopping or continuing in pregnancy (MAMA) trial
Amount £3,100,000 (GBP)
Funding ID NIHR153577 
Organisation National Institute for Health and Care Research 
Sector Public
Country United Kingdom
Start 08/2023 
End 08/2029
 
Title Measuring family spillover effects with EuroQol instruments over time 
Description The impact of neonatal care interventions on health outcomes affects not only the newborn but their mothers and other family members. These spillover effects are seldom included in economic evaluation of neonatal care technologies because data to evaluate these wider benefits are rarely collected. The ongoing withholding enteral feeds around blood transfusion (WHEAT) study is a multi-centre randomised controlled trial comparing withholding milk feeds before, during and after blood transfusion in preterm infants to reduce the risk of necrotising enterocolitis (NEC). An economic evaluation alongside the trial was not originally funded but investigators have now secured additional funding from the Bukhman Foundation to collect the relevant data for a cost analysis associated with NEC and an economic evaluation in the UK. In addition to resource use, planned data collection will include EQ-TIPS (for newborns), EQ-5D-5L (for parents), EQ-HWB (for parents) and EQ-5D-Y-3L (for siblings) at neonatal discharge, 6 months and 1 year follow-up. This longitudinal design will provide an excellent resource to understand whether EuroQol instruments used in the family context are able to capture spillover effects over time. 
Type Of Material Physiological assessment or outcome measure 
Year Produced 2020 
Provided To Others? Yes  
Impact This research proposal provide a rare opportunity to understand whether the beta version of some of the EUROQOL Group's instruments (e.g. EQ-TIPS, EQ-5D)are fit for purpose to be used for the evaluation of family spillover effects. Conducting research in the family context of a baby with a neonatal condition is very expensive and it would be virtually impossible for the Group to support a study like this one in isolation. Our aim is to provide evidence that EuroQol instruments are able to capture family health spillover in the context of caring for a baby with NEC. If this is demonstrated, it will send an important signal to the scientific community as it will encourage the use of the instrument for the evaluation of spillover effects in the family context in future studies. 
 
Title Use of routinely recorded neonatal data in prospective randomised controlled trials 
Description I have pioneered the use of routinely recorded neonatal data held in the National Neonatal Research Database (NNRD) for prospective neonatal clinical trials through the WHEAT pilot trial, WHEAT trial and neoGASTRIC trials. This has reduced burden on clinical teams and has increased trial efficiency. Within the WHEAT pilot trial I have demonstrated the validity and accuracy of using routinely recorded data for trials in the neonatal context. 
Type Of Material Improvements to research infrastructure 
Year Produced 2021 
Provided To Others? Yes  
Impact Increasing numbers of neonatal trials using the NNRD for some data capture (including BASE trial) 
 
Description Collaboration in developing a neonatal clinical trial using electronic health records 
Organisation London School of Hygiene and Tropical Medicine (LSHTM)
Department Faculty of Epidemiology and Population Health
Country United Kingdom 
Sector Academic/University 
PI Contribution Developed proposed neonatal nutrition clinical trial protocol. Undertaking feasibility study. Statistical expertise regarding trial design. Neonatal clinical trial expertise.
Collaborator Contribution Regulatory expertise. Neonatal clinical expertise. Experience of running pragmatic, multi-centre neonatal clinical trials. Experience of running randomised clinical trials using electronic health records in general practice.
Impact Protocol for proposed neonatal nutrition clinical trials using electronic health records NIHR HTA application for a proposed neonatal nutrition clinical trials using electronic health records
Start Year 2014
 
Description Collaboration in developing a neonatal clinical trial using electronic health records 
Organisation University of Liverpool
Department Department of Women's and Children's Health
Country United Kingdom 
Sector Academic/University 
PI Contribution Developed proposed neonatal nutrition clinical trial protocol. Undertaking feasibility study. Statistical expertise regarding trial design. Neonatal clinical trial expertise.
Collaborator Contribution Regulatory expertise. Neonatal clinical expertise. Experience of running pragmatic, multi-centre neonatal clinical trials. Experience of running randomised clinical trials using electronic health records in general practice.
Impact Protocol for proposed neonatal nutrition clinical trials using electronic health records NIHR HTA application for a proposed neonatal nutrition clinical trials using electronic health records
Start Year 2014
 
Description Collaboration in developing a neonatal clinical trial using electronic health records 
Organisation University of Nottingham
Department Neonatal Medicine
Country United Kingdom 
Sector Academic/University 
PI Contribution Developed proposed neonatal nutrition clinical trial protocol. Undertaking feasibility study. Statistical expertise regarding trial design. Neonatal clinical trial expertise.
Collaborator Contribution Regulatory expertise. Neonatal clinical expertise. Experience of running pragmatic, multi-centre neonatal clinical trials. Experience of running randomised clinical trials using electronic health records in general practice.
Impact Protocol for proposed neonatal nutrition clinical trials using electronic health records NIHR HTA application for a proposed neonatal nutrition clinical trials using electronic health records
Start Year 2014
 
Description Developing Point-of-Care neonatal trials 
Organisation Örebro University
Country Sweden 
Sector Academic/University 
PI Contribution Wider development and dissemination of point-of-care trial methodology developed at Orebro.
Collaborator Contribution Intellectual input towards development of point-of-care trials
Impact 1. Development of WHEAT randomised point-of-care trial 2. Input into the development of a European registry trial platform - initial meeting 23rd November 2015
Start Year 2014
 
Description International Perinatal Research (INPRES) Partnership 
Organisation Murdoch Children's Research Institute
Country Australia 
Sector Academic/University 
PI Contribution The INPRES Partnership is a collaboration between institutions around the world, leading and undertaking research in the field of perinatology. I am leading the neoGASTRIC trial, the largest collaborative individually randomised neonatal trial yet undertaken and a key part of this collaboration
Collaborator Contribution Within the INPRES collaboration we are undertaking a range of activities including prioritisation of research questions and other collaborative trial bids - these have been led by partner organisations
Impact The James Lind Alliance (JLA) Priority Setting Partnership in the Most Premature Babies: in progress https://www.npeu.ox.ac.uk/most-premature-babies
Start Year 2021
 
Description International Perinatal Research (INPRES) Partnership 
Organisation University of Oxford
Department National Perinatal Epidemiology Unit Oxford
Country United Kingdom 
Sector Academic/University 
PI Contribution The INPRES Partnership is a collaboration between institutions around the world, leading and undertaking research in the field of perinatology. I am leading the neoGASTRIC trial, the largest collaborative individually randomised neonatal trial yet undertaken and a key part of this collaboration
Collaborator Contribution Within the INPRES collaboration we are undertaking a range of activities including prioritisation of research questions and other collaborative trial bids - these have been led by partner organisations
Impact The James Lind Alliance (JLA) Priority Setting Partnership in the Most Premature Babies: in progress https://www.npeu.ox.ac.uk/most-premature-babies
Start Year 2021
 
Description Process evaluation within neonatal clinical trials 
Organisation University of Liverpool
Department School of Life Sciences Liverpool
Country United Kingdom 
Sector Academic/University 
PI Contribution We have developed a strong collaborative relationship with the trial process evaluation group based at the University of Liverpool, this has led to funding for embedded process evaluation within the neoGASTRIC trial and has informed trial processes. This has further developed opt-out consent for neonatal trials and evaluated it internationally.
Collaborator Contribution The partner organisation have led the process evaluation methodology which has been embedded into the trial.
Impact No outcomes as yet
Start Year 2023
 
Description neoGASTRIC trial Australia 
Organisation Monash University
Country Australia 
Sector Academic/University 
PI Contribution Developed a multicentre clinical trial to run in Australia and the UK - this will be the largest individually randomised neonatal clinical trial ever undertaken
Collaborator Contribution Led collaboration, led development of trial protocol, built collaborating team
Impact Multidisciplinary collaboration including: clinical academics, nurses, statisticians, health economists, parents
Start Year 2021
 
Title Routine measurement of gastric residual volumes 
Description Largest preterm individually randomised trial internationally, currently underway - recruiting ahead of time and target 
Type Therapeutic Intervention - Psychological/Behavioural
Current Stage Of Development Late clinical evaluation
Year Development Stage Completed 2025
Development Status Under active development/distribution
Clinical Trial? Yes
Impact Utilising and evaluating a novel approach to consent and recruitment in clinical trial - op-out consent for comparative effectiveness, low additional risk trials. 
 
Description 'Opt-out consent and Platform trials' podcast with Prof Tony Gordon 
Form Of Engagement Activity A broadcast e.g. TV/radio/film/podcast (other than news/press)
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Professional Practitioners
Results and Impact PicPod podcast where features, challenges and advantages of opt-out consent and platform trials were discussed.
Year(s) Of Engagement Activity 2022
URL https://picpod.net/